Hims & Hers Health, Inc. (NYSE: HIMS) reported Q2 EPS of ($0.37), $0.32 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $753 million versus the consensus estimate of $691.65 million.

GUIDANCE:

Hims & Hers Health, Inc. sees FY2026 revenue of $3.1-3.3 billion, versus the consensus of $3.05 billion.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.